1. All Products
  2. AMOXICILLIN 1g / CLAVULANIC acid 200mg, powder
Public Pricelist

AMOXICILLIN 1g / CLAVULANIC acid 200mg, powder

https://medicalguidelines.msf.org/en/node/735
https://unicat.msf.org/cat/product/11623
STD DINJAMOC1V2

Valid Article

Former Code(s): -X
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
6.2.1 - Access group antibiotics
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01CR02
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit. A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

AMOXICILLIN/CLAVULANIC acid

Therapeutic Action

Combination of two antibacterials

The addition of clavulanic acid to amoxicillin extends its spectrum of activity to cover beta-lactamase producing Gram-positive and Gram-negative organisms, including some Gram-negative anaerobes.

Indications

Erysipelas and cellulitis

Necrotizing infections of the skin and soft tissues

Severe postpartum upper genital tract infection

Instructions for use

Reconstitute the powder vial with 20 ml of water for injection or 0.9% NaCl.

Must be given as slow IV injection or infusion.

Precautions for Use

Not compatible with dextrose

Storage

  • Below 25°C
  • After reconstitution, use the solution immediately
  • Discard any unused open vial.